Contents:

1. Market Definition REPORT COVERAGE MARKET SECTORS. Hormone-Based Products Oral Contraceptives Depot Contraceptives Barrier Products Intra-Uterine Products Other Methods MARKET TRENDS Hormonal Products Show Steady Growth Demand for LARCs Increases Condom Volumes Are Sluggish Consumers Respond to New Lubricants and Sex Aids New Developments in Hormonal Contraceptives Sexual Behaviour Shows a Stable Trend Sexually Transmitted Infections Are Still Increasing ECONOMIC TRENDS Population Table 1: UK Resident Population Estimates by Sex (000), Mid-Years 2003-2007 Gross Domestic Product Table 2: UK Gross Domestic Product at Current and Annual Chain-Linked Prices (£m), 2003-2007 Inflation Table 3: UK Rate of Inflation (%), 2003-2007 Unemployment Table 4: Actual Number of Unemployed Persons in the UK (million), 2003-2007 MARKET POSITION 2. Market Size THE TOTAL MARKET Table 5: The UK Contraception Market by Sector by Value (£000), Years Ending May 2004-2008 BY MARKET SECTOR Hormone-Based Products Table 6: The UK Contraception Market — Hormone-Based Products by Sector by Value (£000 and %), Years Ending May 2004-2008 Barrier Products Table 7: The UK Contraception Market — Barrier Products by Sector by Value (£000 and %), Years Ending May 2004-2008 Intra-Uterine Products Table 8: The UK Contraception Market — Intra-Uterine Products by Sector by Value (£000 and %), Years Ending May 2004-2008 Other Methods 3. Industry Background RECENT HISTORY NUMBER OF COMPANIES EMPLOYMENT Table 9: Employment, R&D Employment, Salaries and Gross Output per Employee in the UK Pharmaceutical Industry (000, %, £m and £), 1980-2006 DISTRIBUTION HOW ROBUST IS THE MARKET? Table 10: Estimated and Projected UK Population by Sex and Age (000), Mid-Years 1971-2026 LEGISLATION KEY TRADE ASSOCIATIONS AND INDUSTRY BODIES Association of the British Pharmaceutical Industry British Pregnancy Advisory Service Brook Advisory Centres Department of Health Family Planning Association The Information Centre Marie Stopes International National Institute for Health and Clinical Excellence National Pharmacy Association Royal Pharmaceutical Society of Great Britain 4. Competitor Analysis THE MARKETPLACE MARKET LEADERS Ansell (UK) Ltd Bayer Schering Pharma Janssen-Cilag Ltd Organon Laboratories Ltd Pfizer Ltd SSL International PLC Other Companies Boots and Superdrug Church & Dwight UK Ltd Condomi Health UK Ltd The Female Health Company (UK) PLC Sutherland Health Group PLC Wyeth Europa Ltd MARKETING ACTIVITY Main Media Advertising Expenditure Table 11: Main Media Advertising Expenditure on Contraceptives and Associated Products by Brand (£000), Years Ending June 2007 and 2008 Exhibitions and Trade Shows 5. Strengths, Weaknesses, Opportunities and Threats 31 STRENGTHS WEAKNESSES OPPORTUNITIES THREATS 6. Buying Behaviour INTRODUCTION Women ‘At Risk’ of Pregnancy Table 12: Proportion of Women Aged 16 to 49 in Great Britain ‘At Risk’ of Pregnancy by Age (%), 2007/2008 USE OF CONTRACEPTION AMONG WOMEN Table 13: Use of Contraception by Women Aged 16 to 49 in Great Britain by Type (%), 2003/2004-2007/2008 By Age Table 14: Use of Contraception by Women Aged 16 to 49 in Great Britain by Type and Age (%), 2007/2008 GP PRESCRIPTIONS Table 15: Cost to the NHS of Contraception Prescriptions by Type (£m), 2003/2004-2007/2008 USE OF FAMILY PLANNING SERVICES Table 16: Family Planning Services Used by Women Aged 16 to 24 in Great Britain (% of women), 2003/2004-2007/2008 THE CONDOM MARKET Reasons for Using Condoms Table 17: Reasons for Using a Condom in Great Britain by Sex (% of respondents), 2003/2004-2007/2008 Demographics of Condom Purchasing Table 18: Purchasing of Condoms by Socio-Demographic Group (% of adults), Year Ending March 2008 Brand Loyalty Table 19: Solus Purchasing of Condoms by Socio-Demographic Group (% of adults), Year Ending March 2008 Volume of Purchasing Table 20: Heavy Purchasers of Condoms by Socio-Demographic Group (% of adults), Year Ending March 2008 7. Current Issues LEVELS OF SEXUAL ACTIVITY NUMBER OF ABORTIONS SEXUALLY TRANSMITTED DISEASES Table 21: Number of Diagnoses of Sexually Transmitted Diseases at Genito-Urinary Medicine Clinics in the UK by Type, 1998-2007 IMPLICATIONS FOR THE CONTRACEPTION MARKET GOVERNMENT RESPONSE LARCs 8. The Global Market MARKET SIZE SUPPLY STRUCTURE INTERNATIONAL RESEARCH PRODUCT DEVELOPMENT 9. Forecasts INTRODUCTION Economic Forecasts Table 22: Economic Forecasts for the UK (000, % and million), 2008-2012 FORECASTS 2009 TO 2013 Table 23: The Forecast UK Contraception Market by Sector by Value (£000), Years Ending May 2009-2013 FUTURE TRENDS Product Development The Male Pill A Long-Acting Future? Over-the-Counter Availability Social Trends A Market for Sexual Enjoyment, Not Just Protection 10. Company Profiles 61 Ansell (UK) Ltd Janssen-Cilag Ltd Organon Laboratories Ltd Pfizer Ltd SSL International PLC 11. Further Sources Associations General Sources Government Sources Other Sources Key Note Sources Understanding TGI Data Number, Profile, Penetration Social Grade Standard Region

Companies Mentioned

-Janssen-Cilag Ltd -Organon Laboratories Ltd -Pfizer Ltd SSL International PLC -Ansell (UK) Ltd -Bayer Schering Pharma -SSL International PLC -Boots and Superdrug -Church & Dwight UK Ltd -Condomi Health UK Ltd -The Female Health Company (UK) PLC -Sutherland Health Group PLC -Wyeth Europa Ltd